Vepdegestrant is a novel proteolysis targeting chimera protein degrader designed to target and degrade the estrogen receptor.
Biotech Analyst Biegler, along with Dr Krishnamurthy, Associate Professor of Medicine & Co-Director of Breast Cancer Program at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback